DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$6.52
Tradestie Score
47
Market Cap
$354.59M
Analyst Upside
+137.7%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.23
|
$386.68M | - | 33 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.90
|
$382.04M | - | 48 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.70
|
$371.64M | - | 34 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$21.82
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$48.21
|
$353.70M | - | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 43 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.06
|
$332.96M | - | 40 | Compare |
|
REPL
Replimune Group, Inc.
|
$14.71
|
$328.62M | - | 29 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$16.63
|
$308.74M | - | 40 | Compare |
More DMAC Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry